Dishman Group reports the successful completion of an inspection by the US Food and Drug Administration (FDA) for its Netherlands site.

Dishman Netherlands, located in Veenendaal, is active in the marketing, sales and manufacture of Vitamin D analogs, Vitamin D, cholesterol, and lanolin related products for key markets as pharmaceutical, cosmetic, food, feed and industry applications.

The inspection was conducted from January 24, 2015 to January 26, 2015. The inspection confirmed the site is compliant with the principles and guidelines of current good manufacturing practices (cGMP).

Source: Dishman Group